Wired Magnetically Assisted Capsule Endoscopy and Esophageal Varices

Sponsor
National Taiwan University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06017102
Collaborator
Insight Medical Solutions (Other)
50
2
16

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to compare the safeness and effectiveness of traditional esophagogastroduodenoscope (EGD) and wired magnetically assisted capsule endoscopy (MACE) in the diagnosis of esophageal varices in biliary atresia (BA) patients. The main questions it aims to answer are:

  • Subjects who do wired magnetically assisted capsule endoscopy do not need to open the mouths during the process, this study also want to know whether wired magnetically assisted capsule endoscopy can reduce the generation of droplets.

  • Diagnostic accuracy between traditional esophagogastroduodenoscope and wired magnetically assisted capsule endoscopy in biliary atresia patients with esophageal varices.

Participants will do either traditional esophagogastroduodenoscope or wired magnetically assisted capsule endoscopy.

Condition or Disease Intervention/Treatment Phase
  • Device: wired magnetic assisted capsule endoscopy
  • Device: esophagogastroduodenoscopy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Difference in Aerosol-generating Amount Between Wired Magnetic-assisted Capsule Endoscopy System and Esophagogastroduodenoscopy Examination of Varices in Biliary Atresia Patients
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: wired magnetic assisted capsule endoscopy

Device: wired magnetic assisted capsule endoscopy
once

Other: esophagogastroduodenoscopy

Device: esophagogastroduodenoscopy
once

Outcome Measures

Primary Outcome Measures

  1. Aerosol-generating amount [1-2 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Biliary atresia patients > 6 years old

  • Vital signs are stable

  • Without acute gastrointestinal bleeding

Exclusion Criteria:
  • Patients with metal implants, metal stent, artificial joints, bone plates, and bone screw

  • Patients with electronic devices, such as pacemakers, cochlear implants, or other implanted electronic medical devices

  • Throat or esophageal obstruction leading to dysphagia patients

  • Consciousness disturbance patients unable to swallow

  • Patients with acute upper gastrointestinal bleeding

  • Patients with platelet lower than 40K or PT INR > 1.5

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • National Taiwan University Hospital
  • Insight Medical Solutions

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT06017102
Other Study ID Numbers:
  • 202210059DIPA
First Posted:
Aug 30, 2023
Last Update Posted:
Aug 30, 2023
Last Verified:
May 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by National Taiwan University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 30, 2023